Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Development of carbohydrate based anticancer agents

Objectif

CarboMed will assess the commercial viability of targeting cancer cell glycosylation as a next-generation therapeutic strategy to treat cancer in the clinic. Carbohydrates (glycans) coat the cell of every organism. The glycosylation pattern of cancer cells is, however, very different from that of healthy cells and is associated with aggressive and invasive forms of cancers. By combining our knowledge on carbohydrate chemistry and cancer immunology we targeted the cancer-cell protecting carbohydrate coat, hampering the cancer's ability to grow and metastasize. In this project, we aim to deliver a technical and commercial proof-of-concept for targeting the glycosylation of cancer cells to ultimately enable clinical studies

Régime de financement

ERC-POC - Proof of Concept Grant

Institution d’accueil

STICHTING RADBOUD UNIVERSITEIT
Contribution nette de l'UE
€ 150 000,00
Adresse
HOUTLAAN 4
6525 XZ Nijmegen
Pays-Bas

Voir sur la carte

Région
Oost-Nederland Gelderland Arnhem/Nijmegen
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Bénéficiaires (1)